KRAS and familial pancreatic carcinoma: Overall, by integrated analysis of TCGA and GEO datasets, our results provide deep understandings of how the KRAS, TP53, CDKN2A and SMAD4 genetic alterations and their related genes influence the clinical overall survival of pancreatic cancer patients.